李洁

洁 李 is currently the Country Clinical Operation Leader at 罗氏(中国)投资有限公司, where they lead and oversee hematology clinical trials while managing a team of 10 colleagues. They have extensive experience in site and study management across various therapeutic areas, including oncology and diabetes, from Phase I to Phase III. Previously, they served in multiple roles at 罗氏公司, providing high-quality leadership and coaching to enhance study management capabilities. 洁 李 holds a Master's degree in Clinical Immunology from 西安交通大学.